Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84.7M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
39.2M
-
Shares change
-
-1.37M
-
Total reported value, excl. options
-
$740M
-
Value change
-
-$25.2M
-
Number of buys
-
51
-
Number of sells
-
-48
-
Price
-
$18.89
Significant Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q3 2021
132 filings reported holding STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share as of Q3 2021.
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.2M shares
of 84.7M outstanding shares and own 46.22% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.66M shares), FRANKLIN RESOURCES INC (2.95M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.37M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.23M shares), First Light Asset Management, LLC (2.19M shares), VANGUARD GROUP INC (2.12M shares), SV Health Investors, LLC (1.82M shares), BAILLIE GIFFORD & CO (1.79M shares), STATE STREET CORP (1.7M shares), and Samsara BioCapital, LLC (1.68M shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.